Transmedics
TMDX
107 hedge funds and large institutions have $774M invested in Transmedics in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 6 closing their positions.
650% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 6
83% more capital invested
Capital invested by funds: $423M → $774M (+$351M)
55% more funds holding
Funds holding: 69 → 107 (+38)
48% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10.3% less ownership
Funds ownership: 78.42% → 68.13% (-10%)
68% less call options, than puts
Call options by funds: $4.19M | Put options by funds: $13.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$8.12M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.62M |
| 4 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$4.38M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
-$69.6M |
| 2 |
Axa
Paris,
France
|
-$8.56M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.33M |
| 5 |
RC
Roubaix Capital
Denver,
Colorado
|
-$4.04M |
TMDX Hedge Fund Activity: Q1 2021 in Review
107 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q1 2021, worth a combined $774M — up 83% from $423M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new TMDX positions and 6 closed out — a net gain of 39 holders — while 34 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $10.3M. The largest seller was Abrams Capital Management, exiting entirely with an estimated $69.6M sold.
- 107 institutional investors held Transmedics (TMDX) as of Q1 2021, up from 69 in Q4 2020.
- Funds reported $774M of Transmedics stock for Q1 2021, up 83% quarter-over-quarter.
- 45 funds opened new Transmedics positions in Q1 2021 and 6 closed out, a net change of +39 holders.
- The largest Transmedics buyer in Q1 2021 was BlackRock, an estimated $10.3M added.
- The largest Transmedics seller in Q1 2021 was Abrams Capital Management, an estimated $69.6M sold.
Based on aggregated 13F filings for Q1 2021.